Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

NSE/REMUS stock hub

NSE/REMUS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/REMUSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/REMUS

In the news

Latest news · NSE/REMUS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E28.3

P25 24.8P50 35.9P75 56.9

ROE18.3

P25 6.3P50 13.6P75 18.1

ROIC11.6

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/REMUS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

INR

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	68
Employees Change	20%
Employees Change Percent	41.67
Enterprise value	INR 9.3B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	INE0O5T01011
Last refreshed	2026-05-10
Market cap	INR 9B
Price	INR 777
Price currency	INR
Rev Per Employee	109,992,647.06x
Sector	Healthcare
Sic	5122
Symbol	nse/REMUS
Website	https://remuspharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.71%
EV Earnings	27.7x
EV/EBIT	18.95x
EV/EBITDA	18.05x
EV/FCF	414.43x
EV/Sales	1.24x
FCF yield	0.25%
P/B ratio	2.67x
P/E ratio	28.28x
P/S ratio	1.21x
PE Ratio3 Y	42.8x
PE Ratio5 Y	47.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.55%
EBITDA Margin	6.79%
FCF margin	0.3%
Gross margin	12.96%
Gross Profit	INR 969.1M
Gross Profit Growth	10.89%
Gross Profit Growth Q	24.06%
Gross Profit Growth3 Y	25.13%
Gross Profit Growth5 Y	67.71%
Net Income	INR 335.1M
Net Income Growth	12.07%
Net Income Growth Q	24.9%
Net Income Growth3 Y	17.76%
Net Income Growth5 Y	100.83%
Pretax Margin	7.12%
Profit Margin	4.48%
Profit Per Employee	INR 4.9M
ROA	7.75
Roa5y	14.31
ROCE	13.12
ROE	18.3
Roe5y	43.95
ROIC	11.64
Roic5y	43.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-18.77%
EPS Growth	7.89
EPS Growth Q	54.16
EPS Growth3 Y	14.65
EPS Growth5 Y	84.44
FCF Growth Q	-13.92%
FCF Growth5 Y	-4.17%
OCF Growth Q	-4.62%
OCF Growth3 Y	71.25%
OCF Growth5 Y	19.03%
Revenue Growth	63.84x
Revenue Growth Q	46.76x
Revenue Growth3 Y	52.01x
Revenue Growth5 Y	108.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 1.89
Assets	INR 5.7B
Cash	INR 209.4M
Current Assets	INR 3.1B
Current Liabilities	INR 1.9B
Debt	INR 160.1M
Debt EBITDA	INR 0.31
Debt Equity	INR 0.05
Debt FCF	INR 7.15
Equity	INR 3.4B
Interest Coverage	37.97
Liabilities	INR 2.3B
Long Term Assets	INR 2.6B
Long Term Liabilities	INR 353.1M
Net Cash	INR 49.3M
Net Cash By Market Cap	INR 0.55
Net Cash Growth	-80.4%
Net Debt EBITDA	INR -0.1
Net Debt Equity	INR -0.01
Net Debt FCF	INR -2.2
Tangible Book Value	INR 3B
Tangible Book Value Per Share	INR 312
WACC	5.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.61
Inventory Turnover	9.08
Net Working Capital	INR 1.1B
Quick ratio	0.86
Working Capital	INR 1.2B
Working Capital Turnover	INR 7.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.88%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 1
Dividend Years	3
Dividend Yield	0.13%
Ex Div Date	2025-11-14
Last Dividend	INR 0.5
Payout Frequency	Semi-Annual
Payout Ratio	1.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-18.76%
200-day SMA	747.5
50-day SMA	653.8
50-day SMA vs 200-day SMA	50under200
All Time High	1,417.4
All Time High Change	-45.19%
All Time High Date	2024-09-03
All Time Low	213.9
All Time Low Change	263.17%
All Time Low Date	2023-05-29
ATR	32.42
Beta	0.25
Beta1y	0.71
Beta2y	0.49
Ch YTD	10.63
High	782.9
High52	1,139.5
High52 Date	2025-05-16
High52ch	-31.83%
Low	738
Low52	580
Low52 Date	2026-03-09
Low52ch	33.94%
Ma50ch	18.82%
Price vs 200-day SMA	3.92%
RSI	71.35
RSI Monthly	51.59
RSI Weekly	55.93
Sharpe ratio	-0.37x
Sortino ratio	-0.47
Total Return	-3.75%
Tr YTD	10.63
Tr1m	22.34%
Tr1w	8.38%
Tr3m	18.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 489.8M
Operating Income Growth	11.78
Operating Income Growth Q	27.29
Operating Income Growth3 Y	20.72
Operating Income Growth5 Y	111.3
Operating margin	6.55

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,448,400%
Net Borrowing	-72,700,000
Shares Insiders	69.5%
Shares Out	11,658,000
Shares Qo Q	-18.98%
Shares Yo Y	3.88%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 22.4M
Average Volume	6,025x
Bv Per Share	321.6
CAPEX	INR -45.4M
Ch1m	22.34
Ch1w	8.38
Ch1y	-18.87
Ch3m	18.24
Ch6m	-3.64
Change	4.01%
Change From Open	2.89
Close	746.9
Days Gap	1.08
Depreciation Amortization	17,700,000
Dollar Volume	7,457,760
Earnings Date	2026-05-15
EBIT	INR 489.8M
EBITDA	INR 507.5M
EPS	INR 27.37
F Score	4
FCF	INR 22.4M
FCF EV Yield	0.24x
FCF Per Share	INR 1.92
Financing CF	-91,600,000
Fiscal Year End	March
Founded	2,015
Goodwill	87,300,000
Graham Number	444.97125
Graham Upside	-42.72
Income Tax	INR 110.9M
Investing CF	-128,600,000
Is Primary Listing	1
Last Earnings Date	2026-02-09
Last Report Date	2025-09-30
Last Split Date	2025-07-04
Last Split Type	Forward
Lynch Fair Value	INR 684
Lynch Upside	-11.93
Ma150	694.5
Ma150ch	11.86%
Ma20	670
Ma20ch	15.94%
Net CF	-152,300,000
Next Earnings Date	2026-05-15
Open	755
P FCF Ratio	402.8
P OCF Ratio	133.1
Payment Date	2025-12-10
Position In Range	86.64
Ppne	90,500,000
Price Date	2026-05-08
Price EBITDA	INR 17.78
Ptbv Ratio	3.03
Relative Volume	1.73x
Revenue	7,479,500,000x
Tax By Revenue	1.48x
Tax Rate	20.83%
Tr6m	-3.58%
Volume	9,600

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/REMUS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$1.00 annual per share

Payout ratio

+1.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

-3.8%

Next ex-dividend date: 2025-11-14

Performance

NSE/REMUS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/REMUS?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+69.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.9%

Negative means the company is buying back shares.

Technical

NSE/REMUS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

71.3

Above 70: short-term overbought

Price vs 200-day MA

+3.9%

50/200-day relationship not available

Beta (5Y)

0.25

Less volatile than the market

Sharpe ratio

-0.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/REMUS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/REMUS stock rating?

nse/REMUS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/REMUS analysis?

The full report lives at /stocks/nse/REMUS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/REMUS?

The latest report frames nse/REMUS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/REMUS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.